The effects of trastuzumab on HER2-mediated cell signaling in CHO cells expressing human HER2

Abstract

We concluded that, in the absence of other HER receptors, trastuzumab exerts its antitumor activity through the induction of ADCC, rather than the inhibition of HER2-homodimerization and phosphorylation.